Erector Spinae Plane Block Versus Perioperative Intravenous Lidocaine for Thoracotomy
1 other identifier
interventional
60
1 country
1
Brief Summary
Thoracotomy surgery is the most painful of all surgical procedures. Inadequate postoperative pain control in these patients may cause serious morbidity related to pulmonary, cardiovascular and emotional systems. Erector Spinae Plane Block (ESPB) was first described in 2016 and, it is frequently used for postoperative analgesia in thoracic surgery. Intravenous lidocaine exhibit analgesic activity through both the peripheral and central nervous system. Intravenous lidocaine has been shown to reduce postoperative pain intensity and accelerate postoperative recovery in many surgeries. The investigators aimed to compare the effect of lidocaine infusion and erector spinae plane block on postoperative opioid consumption and pain scores.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2020
CompletedFirst Posted
Study publicly available on registry
January 9, 2020
CompletedStudy Start
First participant enrolled
September 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2022
CompletedMay 16, 2022
May 1, 2022
5 months
January 7, 2020
May 13, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Opioid Consumption
First 24 hours total fentanyl consumption with patient controlled analgesia
First 24 hours total opioid consumption
Secondary Outcomes (1)
Visual analog pain score
Postoperative 24 hour
Study Arms (3)
Group ESPB
ACTIVE COMPARATORUltrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine and Saline iv. bolus and infusion (same volume as Group Lidocaine)
Group Lidocaine
ACTIVE COMPARATOR1.5 mg / kg lidocaine iv. bolus and, 1.5mg / kg / h lidocaine iv. infusion and, Ultrasound-guided erector spinae plane block with 20 ml saline
Group Control
SHAM COMPARATORUltrasound-guided erector spinae plane block with 20 ml saline and, Saline iv. bolus and infusion (same volume as Group Lidocaine)
Interventions
Ultrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine
Ultrasound-guided erector spinae plane block with 20 ml saline
Same volume saline solution bolus and infusion as Group Lidocaine
1.5 mg / kg lidocaine iv. bolus and, 1.5mg / kg / h lidocaine iv. infusion
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologist's physiologic state I-III patients undergoing thoracotomy surgery
You may not qualify if:
- chronic pain, bleeding disorders, renal or hepatic insufficiency, non cooperative patient,
- Patients with allergies to one of the drugs used in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ataturk University
Erzurum, Turkey (Türkiye)
Related Publications (2)
Forero M, Rajarathinam M, Adhikary S, Chin KJ. Erector spinae plane (ESP) block in the management of post thoracotomy pain syndrome: A case series. Scand J Pain. 2017 Oct;17:325-329. doi: 10.1016/j.sjpain.2017.08.013. Epub 2017 Sep 12.
PMID: 28919152BACKGROUNDMoeen SM, Moeen AM. Usage of Intravenous Lidocaine Infusion with Enhanced Recovery Pathway in Patients Scheduled for Open Radical Cystectomy: A Randomized Trial. Pain Physician. 2019 Mar;22(2):E71-E80.
PMID: 30921979BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
January 7, 2020
First Posted
January 9, 2020
Study Start
September 29, 2021
Primary Completion
March 1, 2022
Study Completion
March 15, 2022
Last Updated
May 16, 2022
Record last verified: 2022-05